Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized PRF for Periodontal Intra-Bony Defects
NCT06625528Phase 1Active, not recruiting
- Sponsor
- Al-Azhar University
- Start
- Nov 2023
- Primary completion
- May 2025
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lyophilized platelet-rich fibrin in periodontitis (3 arms), sponsored by Al-Azhar University. Primary endpoints: Probing Pocket Depth reduction at 9 months, Clinical Attachment Level gain at 9 months and 2 more. Started Nov 2023; status: active, not recruiting.
02
Drugs
lyophilized platelet-rich fibrin
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT06625528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06625528.